TITAN PHARMACEUTICALS INC — Director's Dealing 2015

Mar 19, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTNP.OB)
CIK: 0000910267
Period of Report: 2015-03-16

Reporting Person: Rubin Marc (Director, Executive Chairman)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-16	Option to Purchase Common Stock	$0.60	A	200000	Acquired	2025-03-16	Common Stock (200000)	Direct

Footnotes

F1: 50% of the options have vested on the grant date and the balance shall vest on the first anniversary of the grant date.